1990
DOI: 10.1002/jcla.1860040316
|View full text |Cite
|
Sign up to set email alerts
|

Potential clinical applications of c‐reactive protein

Abstract: This article reviews the clinical applications of C-reactive protein (CRP). This acute-phase protein is a distinct and sensitive marker for inflammation and tissue injury. It is a simple, fast, and relatively inexpensive latex agglutination test. The aspects of CRP reviewed include diagnostic support, serial measurements to evaluate disease course and therapeutic response, and screening studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
36
0
2

Year Published

1993
1993
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(40 citation statements)
references
References 57 publications
2
36
0
2
Order By: Relevance
“…According to the present findings, IL-6 concentration was increased in TPE and PPE, but these findings were nonsignificant after fitting the logit model. CRP is an acute-phase protein widely used as a marker of inflammation and tissue injury [19]. CRP concentration level has been studied in pleural fluid and been found to be higher in benign than in malignant exudates [20].…”
Section: Biological Markers In Pleural Effusion Zd Daniil Et Almentioning
confidence: 99%
“…According to the present findings, IL-6 concentration was increased in TPE and PPE, but these findings were nonsignificant after fitting the logit model. CRP is an acute-phase protein widely used as a marker of inflammation and tissue injury [19]. CRP concentration level has been studied in pleural fluid and been found to be higher in benign than in malignant exudates [20].…”
Section: Biological Markers In Pleural Effusion Zd Daniil Et Almentioning
confidence: 99%
“…13,14 In fact, tear samples from glaucoma patients have been shown to have greater amounts of infl ammatory cytokines compared to their normal counterparts. 49 Although fi brinogen is suspected as being upregulated indirectly (secondary to the infl ammatory cytokines), 50 it (ie, fi brinogen), 12 CRP, 11 and multiple cytokines, 13,14 specifi cally IL-1α and β, IL-2, IL-4, IL-6, IL-10, IL-12, IL-23, and TNFα, have long been described as conventional markers of infl ammation. used in concentrations varying from 0.015% to 0.05%, 4 although the American College of Toxicology has concluded that BAK can be safely used as an antimicrobial agent at concentrations up to 0.1%.…”
Section: 3mentioning
confidence: 99%
“…8 BAK, is known to be degraded into hydrogen peroxide (H 2 O 2 ), 8 which, in even small amounts as low as 30 parts per million (0.003%), is known to be an ophthalmic irritant. 9,10 C-reactive protein (CRP), 11 fi brinogen, 12 and multiple cytokines, 13,14 specifi cally interleukin (IL-)1α and β, IL-2, IL-4, IL-6, IL-10, IL-12, IL-23, and tumor necrosis factor (TNF-)α, have long been described as conventional biomarkers of infl ammation. Increased toxicity should cause a localized infl ammatory response with concomitant increased elaboration of these infl ammatory biomarkers.…”
Section: Epstein Chen and Asbell 416mentioning
confidence: 99%
“…8 C-reactive protein (CRP) is secreted by the liver, and plasma CRP rapidly rises in response to inflammation, so it is an important biomarker of systemic inflammation. 9 CRP correlates with long-term mortality and morbidity in patients with COPD, rheumatoid disease, coronary artery disease, and chronic inflammation. 10,11 Response to antiinflammatory treatment can be monitored with CRP.…”
Section: Introductionmentioning
confidence: 99%